NYSE American - Nasdaq Real Time Price USD

Zomedica Corp. (ZOM)

Compare
0.1299
+0.0032
+(2.53%)
As of 12:31:30 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
26,727.0000
25,186.0000
18,930.0000
4,133.0000
--
Cost of Revenue
8,115.0000
7,868.0000
5,462.0000
1,079.0000
--
Gross Profit
18,612.0000
17,318.0000
13,468.0000
3,054.0000
--
Operating Expense
56,870.0000
48,910.0000
35,391.0000
24,428.0000
16,764.9780
Operating Income
-38,258.0000
-31,592.0000
-21,923.0000
-21,374.0000
-16,764.9780
Net Non Operating Interest Income Expense
4,257.0000
5,283.0000
2,700.0000
351.0000
32.1270
Other Income Expense
-28,070.0000
-9,551.0000
-158.0000
306.0000
-178.9330
Pretax Income
-62,071.0000
-35,860.0000
-19,381.0000
-20,717.0000
-16,911.7840
Tax Provision
123.0000
-1,331.0000
-2,366.0000
-2,333.0000
--
Net Income Common Stockholders
-62,194.0000
-34,529.0000
-17,015.0000
-50,423.0000
-16,911.7840
Diluted NI Available to Com Stockholders
-62,194.0000
-34,529.0000
-17,015.0000
-50,423.0000
-16,911.7840
Basic EPS
-0.07
-0.04
-0.02
-0.05
-0.05
Diluted EPS
-0.07
-0.04
-0.02
-0.05
-0.05
Basic Average Shares
979,949.6680
979,949.6680
979,949.6680
956,533.7610
364,444.6640
Diluted Average Shares
979,949.6680
979,949.6680
979,949.6680
956,533.7610
364,444.6640
Total Operating Income as Reported
-54,282.0000
-31,592.0000
-21,923.0000
-21,374.0000
-16,764.9780
Rent Expense Supplemental
--
--
--
--
299.9470
Total Expenses
64,985.0000
56,778.0000
40,853.0000
25,507.0000
16,764.9780
Net Income from Continuing & Discontinued Operation
-62,194.0000
-34,529.0000
-17,015.0000
-18,384.0000
-16,911.7840
Normalized Income
-40,089.8000
-23,329.7028
-16,882.4338
-18,609.3963
-16,724.2500
Interest Income
4,257.0000
5,458.0000
2,701.0000
357.0000
32.8590
Interest Expense
--
175.0000
1.0000
6.0000
0.7320
Net Interest Income
4,257.0000
5,283.0000
2,700.0000
351.0000
32.1270
EBIT
-62,071.0000
-35,685.0000
-19,380.0000
-20,711.0000
-16,911.0520
EBITDA
-54,265.0000
-29,387.0000
-15,338.0000
-19,572.0000
-16,381.0320
Reconciled Cost of Revenue
8,115.0000
7,868.0000
5,462.0000
1,079.0000
--
Reconciled Depreciation
7,806.0000
6,298.0000
4,042.0000
1,139.0000
530.0200
Net Income from Continuing Operation Net Minority Interest
-62,194.0000
-34,529.0000
-17,015.0000
-18,384.0000
-16,911.7840
Total Unusual Items Excluding Goodwill
-27,980.0000
-11,631.0000
-151.0000
254.0000
-187.5340
Total Unusual Items
-27,980.0000
-11,631.0000
-151.0000
254.0000
-187.5340
Normalized EBITDA
-26,285.0000
-17,756.0000
-15,187.0000
-19,826.0000
-16,193.4980
Tax Rate for Calcs
0.0002
0.0000
0.0001
0.0001
--
Tax Effect of Unusual Items
-5,875.8000
-431.7028
-18.4338
28.6037
--
12/31/2020 - 11/21/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SENS Senseonics Holdings, Inc.
0.7010
-5.96%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.0318
+0.17%
 
CODX Co-Diagnostics, Inc.
0.7512
+1.26%
 
QSI Quantum-Si incorporated
2.2387
+10.30%
 
AIMD Ainos, Inc.
0.6901
-1.41%
 
VTAK Catheter Precision, Inc.
0.4205
-10.87%
 
XAIR Beyond Air, Inc.
0.3480
-3.29%
 
TNON Tenon Medical, Inc.
1.6893
+1.16%
 
PACB Pacific Biosciences of California, Inc.
1.8000
-2.70%
 
BFLY Butterfly Network, Inc.
3.6950
+9.64%